Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of hydrogel designed to treat patients with chronic wounds. SolasCure is based in Cambridge, United Kingdom and was founded in 2017. Its last reported valuation was $57 million in Jan 2021. It has raised $34.2 million.
Last reported valuation
$57.0M
Oct 2026
Priced at
—
Total raised
$34.2M
Last round
—
Team — not yet on record
No current team members for SolasCure are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SolasCure with a free account
·The complete investor list: 17 names
·Watch SolasCure: the Monday email on marks, rounds and moves
